75 related articles for article (PubMed ID: 27880939)
21. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
22. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the transcriptional repressor complex BCL-6/BCoR leads to nuclear aggregates distinct from classical aggresomes.
Buchberger E; El Harchi M; Payrhuber D; Zommer A; Schauer D; Simonitsch-Klupp I; Bilban M; Brostjan C
PLoS One; 2013; 8(10):e76845. PubMed ID: 24146931
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase D2 and heat shock protein 90 beta are required for BCL6-associated zinc finger protein mRNA stabilization induced by vascular endothelial growth factor-A.
Miwa D; Sakaue T; Inoue H; Takemori N; Kurokawa M; Fukuda S; Omi K; Goishi K; Higashiyama S
Angiogenesis; 2013 Jul; 16(3):675-88. PubMed ID: 23515950
[TBL] [Abstract][Full Text] [Related]
25. "Sprouting angiogenesis", a reappraisal.
Ribatti D; Crivellato E
Dev Biol; 2012 Dec; 372(2):157-65. PubMed ID: 23031691
[TBL] [Abstract][Full Text] [Related]
26. BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis.
Ohnuki H; Inoue H; Takemori N; Nakayama H; Sakaue T; Fukuda S; Miwa D; Nishiwaki E; Hatano M; Tokuhisa T; Endo Y; Nose M; Higashiyama S
Blood; 2012 Mar; 119(11):2688-98. PubMed ID: 22279058
[TBL] [Abstract][Full Text] [Related]
27. Identification and functional analysis of endothelial tip cell-enriched genes.
del Toro R; Prahst C; Mathivet T; Siegfried G; Kaminker JS; Larrivee B; Breant C; Duarte A; Takakura N; Fukamizu A; Penninger J; Eichmann A
Blood; 2010 Nov; 116(19):4025-33. PubMed ID: 20705756
[TBL] [Abstract][Full Text] [Related]
28. A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.
Cerchietti LC; Ghetu AF; Zhu X; Da Silva GF; Zhong S; Matthews M; Bunting KL; Polo JM; Farès C; Arrowsmith CH; Yang SN; Garcia M; Coop A; Mackerell AD; Privé GG; Melnick A
Cancer Cell; 2010 Apr; 17(4):400-11. PubMed ID: 20385364
[TBL] [Abstract][Full Text] [Related]
29. BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning.
Sakano D; Kato A; Parikh N; McKnight K; Terry D; Stefanovic B; Kato Y
Dev Cell; 2010 Mar; 18(3):450-62. PubMed ID: 20230751
[TBL] [Abstract][Full Text] [Related]
30. Role of the transcriptional corepressor Bcor in embryonic stem cell differentiation and early embryonic development.
Wamstad JA; Corcoran CM; Keating AM; Bardwell VJ
PLoS One; 2008 Jul; 3(7):e2814. PubMed ID: 18795143
[TBL] [Abstract][Full Text] [Related]
31. CtBP is an essential corepressor for BCL6 autoregulation.
Mendez LM; Polo JM; Yu JJ; Krupski M; Ding BB; Melnick A; Ye BH
Mol Cell Biol; 2008 Apr; 28(7):2175-86. PubMed ID: 18212045
[TBL] [Abstract][Full Text] [Related]
32. Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells.
Fan Y; Wang Y; Tang Z; Zhang H; Qin X; Zhu Y; Guan Y; Wang X; Staels B; Chien S; Wang N
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):315-21. PubMed ID: 18048767
[TBL] [Abstract][Full Text] [Related]
33. Left-sided embryonic expression of the BCL-6 corepressor, BCOR, is required for vertebrate laterality determination.
Hilton EN; Manson FD; Urquhart JE; Johnston JJ; Slavotinek AM; Hedera P; Stattin EL; Nordgren A; Biesecker LG; Black GC
Hum Mol Genet; 2007 Jul; 16(14):1773-82. PubMed ID: 17517692
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Bcor expression in mouse development.
Wamstad JA; Bardwell VJ
Gene Expr Patterns; 2007 Apr; 7(5):550-7. PubMed ID: 17344103
[TBL] [Abstract][Full Text] [Related]
35. Plastic downregulation of the transcriptional repressor BCL6 during maturation of human dendritic cells.
Pantano S; Jarrossay D; Saccani S; Bosisio D; Natoli G
Exp Cell Res; 2006 May; 312(8):1312-22. PubMed ID: 16455075
[TBL] [Abstract][Full Text] [Related]
36. IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3.
Tsuyama N; Danjoh I; Otsuyama K; Obata M; Tahara H; Ohta T; Ishikawa H
Biochem Biophys Res Commun; 2005 Nov; 337(1):201-8. PubMed ID: 16188230
[TBL] [Abstract][Full Text] [Related]
37. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
[TBL] [Abstract][Full Text] [Related]
38. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
Jardin F; Sahota SS
Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
[TBL] [Abstract][Full Text] [Related]
39. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.
Cattoretti G; Pasqualucci L; Ballon G; Tam W; Nandula SV; Shen Q; Mo T; Murty VV; Dalla-Favera R
Cancer Cell; 2005 May; 7(5):445-55. PubMed ID: 15894265
[TBL] [Abstract][Full Text] [Related]
40. Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome.
Horn D; Chyrek M; Kleier S; Lüttgen S; Bolz H; Hinkel GK; Korenke GC; Riess A; Schell-Apacik C; Tinschert S; Wieczorek D; Gillessen-Kaesbach G; Kutsche K
Eur J Hum Genet; 2005 May; 13(5):563-9. PubMed ID: 15770227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
